Thymoquinone, an active ingredient isolated from Nigella sativa, has been reported to have anti-inflammatory effects. However, the anti-inflammatory effect of thymoquinone on IL-1β-stimulated osteoarthritis chondrocytes remains unclear. In this study, we designed to investigate the anti-inflammatory effects and elucidated the underlying mechanism of thymoquinone on IL-1β-stimulated human osteoarthritis chondrocytes. The effects of thymoquinone on inflammatory mediators COX-2, iNOS, NO, PGE2, as well as MMP-1, MMP3, MMP13 production were detected. The results demonstrated that thymoquinone concentration-dependently inhibited IL-1β-induced COX-2, iNOS, NO, and PGE2 production. Thymoquinone also suppressed IL-1β-induced MMP-1, MMP3, and MMP13 production. We found that thymoquinone significantly inhibited IL-1β-induced NF-κB activation and IκBα degradation. In addition, thymoquinone was found to suppress IL-1β-induced mitogen-activated protein kinases (MAPKs) activation. In conclusion, thymoquinone inhibited IL-1β-induced inflammatory mediator production by inhibition of NF-κB and MAPKs signaling pathways in osteoarthritis chondrocytes. Thymoquinone may be a potential agent in the treatment of osteoarthritis.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Moe, R.H., T. Uhlig, I. Kjeken, K.B. Hagen, T.K. Kvien, and M. Grotle. 2010. Multidisciplinary and multifaceted outpatient management of patients with osteoarthritis: protocol for a randomised, controlled trial. BMC Musculoskeletal Disorders 11: 253.
Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, et al. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and Rheumatism 58: 15–25.
Melchiorri, C., R. Meliconi, L. Frizziero, T. Silvestri, L. Pulsatelli, I. Mazzetti, R.M. Borzi, M. Uguccioni, and A. Facchini. 1998. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis and Rheumatism 41: 2165–2174.
Fernandes, J.C., J. Martel-Pelletier, and J.P. Pelletier. 2002. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39: 237–246.
Honorati, M.C., L. Cattini, and A. Facchini. 2004. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis and Cartilage 12: 683–691.
Lianxu, C., J. Hongti, and Y. Changlong. 2006. NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis and Cartilage 14: 367–376.
Tetlow, L.C., D.J. Adlam, and D.E. Woolley. 2001. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis and Rheumatism 44: 585–594.
Chowdhury, T.T., D.L. Bader, and D.A. Lee. 2001. Dynamic compression inhibits the synthesis of nitric oxide and PGE(2) by IL-1beta-stimulated chondrocytes cultured in agarose constructs. Biochemical and Biophysical Research Communications 285: 1168–1174.
Vergnolle, N., J.L. Wallace, N.W. Bunnett, and M.D. Hollenberg. 2001. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends in Pharmacological Sciences 22: 146–152.
Moon, D.O., M.O. Kim, Y.H. Choi, Y.M. Park, and G.Y. Kim. 2010. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. International Immunopharmacology 10: 605–610.
Abu-Dahab, R., F. Odeh, S.I. Ismail, H. Azzam, and A. Al Bawab. 2013. Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles. Pharmazie 68: 939–944.
Galaly, S.R., O.M. Ahmed, and A.M. Mahmoud. 2014. Thymoquinone and curcumin prevent gentamicin-induced liver injury by attenuating oxidative stress, inflammation and apoptosis. Journal of Physiology and Pharmacology 65: 823–832.
Khalife, R., H. el Stephany, O. Tarras, M.H. Hodroj, and S. Rizk. 2014. Antiproliferative and proapoptotic effects of topotecan in combination with thymoquinone on acute myelogenous leukemia. Clinical Lymphoma, Myeloma & Leukemia 14(Suppl): S46–S55.
Hosseini, M., S. Zakeri, S. Khoshdast, F.T. Yousefian, M. Rastegar, F. Vafaee, S. Kahdouee, F. Ghorbani, H. Rakhshandeh, and S.A. Kazemi. 2012. The effects of Nigella sativa hydro-alcoholic extract and thymoquinone on lipopolysaccharide - induced depression like behavior in rats. Journal of Pharmacology Bioallied Science 4: 219–225.
Alkharfy, K.M., N.M. Al-Daghri, O.S. Al-Attas, and M.S. Alokail. 2011. The protective effect of thymoquinone against sepsis syndrome morbidity and mortality in mice. International Immunopharmacology 11: 250–254.
Cheng, A.W., T.V. Stabler, M. Bolognesi, and V.B. Kraus. 2011. Selenomethionine inhibits IL-1beta inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis and Cartilage 19: 118–125.
Sandell, L.J., X. Xing, C. Franz, S. Davies, L.W. Chang, and D. Patra. 2008. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis and Cartilage 16: 1560–1571.
Towle, C.A., H.H. Hung, L.J. Bonassar, B.V. Treadwell, and D.C. Mangham. 1997. Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. Osteoarthritis and Cartilage 5: 293–300.
Chowdhury, T.T., D.L. Bader, and D.A. Lee. 2006. Dynamic compression counteracts IL-1beta induced iNOS and COX-2 activity by human chondrocytes cultured in agarose constructs. Biorheology 43: 413–429.
Woodell-May, J., A. Matuska, M. Oyster, Z. Welch, K. O'Shaughnessey, and J. Hoeppner. 2011. Autologous protein solution inhibits MMP-13 production by IL-1beta and TNFalpha-stimulated human articular chondrocytes. Journal of Orthopaedic Research 29: 1320–1326.
Aida, Y., M. Maeno, N. Suzuki, H. Shiratsuchi, M. Motohashi, and H. Matsumura. 2005. The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sciences 77: 3210–3221.
Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16: 225–260.
Lawrence, T., M. Bebien, G.Y. Liu, V. Nizet, and M. Karin. 2005. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 1138–1143.
Tak, P.P., and G.S. Firestein. 2001. NF-kappaB: a key role in inflammatory diseases. Journal of Clinical Investigation 107: 7–11.
De Martin, R., M. Hoeth, R. Hofer-Warbinek, and J.A. Schmid. 2000. The transcription factor NF-kappa B and the regulation of vascular cell function. Arteriosclerosis, Thrombosis, and Vascular Biology 20: E83–E88.
Ghosh, M., V. Aguirre, K. Wai, H. Felfly, W.D. Dietrich, and D.D. Pearse. 2015. The Interplay between Cyclic AMP, MAPK, and NF-kappa B pathways in response to proinflammatory signals in microglia. Biomedical Research International 2015: 308461.
Conflict of Interest
The authors have no conflict of interest to declare.
About this article
Cite this article
Wang, D., Qiao, J., Zhao, X. et al. Thymoquinone Inhibits IL-1β-Induced Inflammation in Human Osteoarthritis Chondrocytes by Suppressing NF-κB and MAPKs Signaling Pathway. Inflammation 38, 2235–2241 (2015). https://doi.org/10.1007/s10753-015-0206-1
- osteoarthritis chondrocyte